EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudieOpen Access · CC BY-NC 4.0

Factors related to first COVID-19 booster vaccine acceptance in Indonesia: A cross-sectional multi-center study

Abdul R Mohi, Ikhwan Y Kusuma, Muhammad N Massi, Muhammad A Bahar

Narra J · 2024

DOI: 10.52225/narra.v4i2.858 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Narra J, 2024. Verfasst von Abdul R Mohi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Master of Pharmacy Program, Faculty of Pharmacy, Universitas Hasanuddin, Makassar, Indonesia. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Immunization, Secondary. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A positive community perception of the coronavirus disease 2019 (COVID-19) vaccination program is crucial for increasing vaccination coverage and achieving herd immunity. This study aimed to identify factors influencing the acceptance of a COVID-19 booster vaccine in Indonesia. It was conducted as a cross-sectional, multicenter study using a validated questionnaire distributed online to Indonesian participants aged 18 years and older. The questionnaire covered sociodemographic characteristics, clinical conditions of both the participants and their closest contacts, the Health Belief Model (HBM) domain, and preferences for the location of receiving a booster vaccine, as well as reasons for declining a booster vaccine. Of 1550 respondents, 78.6% had received the first COVID-19 booster dose. Sociodemographic factors influencing first booster vaccine acceptance in Indonesia included age (OR36–45 vs 18–25 years: 2.43; 95%CI: 1.13–5.24; OR>45 vs 18–25 years: 3.58, 95%CI: 1.96–6.52), length of education (OR13–16 vs 16 vs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19Immunization, SecondaryHumansIndonesiaCross-Sectional StudiesMaleAdultFemaleMiddle AgedAdolescentSurveys and QuestionnairesYoung AdultPatient Acceptance of Health CareSARS-CoV-2

Stichwörter der Autor:innen

COVID-19Indonesiaboosterhealth belief modelvaccine acceptance

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Master of Pharmacy Program, Faculty of Pharmacy, Universitas Hasanuddin, Makassar, Indonesia.
  • Pharmacy Study Program, Faculty of Health, Universitas Harapan Bangsa, Purwokerto, Indonesia.
  • Institute of Clinical Pharmacy, University of Szeged, Szeged, Hungary.
  • Department of Clinical Microbiology, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.
  • Department of Pharmacy, Faculty of Pharmacy, Universitas Hasanuddin, Makassar, Indonesia.

Zitieren

APA

Mohi, A. R., Kusuma, I. Y., Massi, M. N., & Bahar, M. A. (2024). Factors related to first COVID-19 booster vaccine acceptance in Indonesia: A cross-sectional multi-center study. Narra J. https://doi.org/10.52225/narra.v4i2.858

Vancouver

Mohi AR, Kusuma IY, Massi MN, Bahar MA. Factors related to first COVID-19 booster vaccine acceptance in Indonesia: A cross-sectional multi-center study. Narra J. 2024. doi:10.52225/narra.v4i2.858

BibTeX
@article{Mohi2024,
  author = {Mohi, Abdul R and Kusuma, Ikhwan Y and Massi, Muhammad N and Bahar, Muhammad A},
  title = {Factors related to first COVID-19 booster vaccine acceptance in Indonesia: A cross-sectional multi-center study},
  journal = {Narra J},
  year = {2024},
  doi = {10.52225/narra.v4i2.858}
}
Kostenlos starten →